Mercado mundial de agentes para la impotencia: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado de agentes para la impotencia

Se espera que el mercado mundial de agentes para la impotencia experimente un crecimiento significativo durante el período de pronóstico. Muchas razones que pueden causar disfunción eréctil, como la aterosclerosis, la hipertensión, la diabetes, la obesidad, la depresión, el estrés y otras afecciones médicas, también impulsarán el mercado mundial de agentes para la impotencia. Los efectos secundarios después de la administración de agentes para la impotencia pueden obstaculizar el mercado de agentes para la impotencia. COVID-19 también tuvo un gran impacto en el crecimiento del mercado.

Data Bridge Market Research analiza la tasa de crecimiento del mercado global de agentes para la impotencia en el período de pronóstico 2022-2029. La CAGR esperada del mercado global de agentes para la impotencia tiende a rondar el 7% en el período de pronóstico mencionado. El mercado se valoró en USD 3.6 mil millones en 2021 y crecería hasta USD 6.19 mil millones para 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Definición de mercado

Los agentes para la impotencia son el tipo de agentes que se utilizan para tratar la disfunción eréctil en los hombres y permiten aumentar las relaciones sexuales. Estos agentes generalmente aumentan la vasodilatación y el flujo sanguíneo al órgano genital masculino y provocan una erección. Está adquiriendo gran importancia para el sector de la salud y se espera que se expanda en los próximos tiempos.

Alcance y segmentación del mercado de agentes para la impotencia

Global Impotence Agents Market Dynamics

Drivers

• Increased Incidence of Erectile Dysfunction

Increasing prevalence of erectile dysfunction are expected to boost the market growth over the forecast period 2022-2029. For instance, according to the World Health Organization (WHO) reports, approximately 150 million people are affected by erectile dysfunction globally, and the number is expected to reach 230 million by 2025. Erectile Dysfunction is a  common medical condition affecting about 15% of men annually. Thus, it boosts market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to prompt the market growth. The segment is expected to boost the global market as most products are available in capsule and tablet form and it is a very suitable route of administration.

Opportunities

• Increasing Demand for Retail Pharmacies

The rise in the number of impotence agents delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Risk of Side-Effects

The varied side-effects associated with impotence agents could curb the growth of the global PDE inhibitors market over a forecast period. Side-effects such as dyspepsia and headache, and to a lesser extent, myalgia, low-back pain, flushing, and rhinitis are visible with the use of impotence agents.

• High Cost

The huge expenditure associated with these agents surely hamper the market growth.

This global impotence agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global impotence agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Impotence Agents Market            

COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term consequences are expected to boost the industry growth during the forecast period. The shift of healthcare infrastructure towards managing COVID-19 has led to drug launch cancellations and delays in clinical trials.

In the post-pandemic era, changes are witnessed in use of different inhibitors. Socioeconomic stressors have also increased the demand for these drugs. Thus, this will leave a significant impact on the global impotence agents market.

Global Impotence Agents Market Scope

The global impotence agents market is segmented on the basis of product, indication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

• Erectile Dysfunction
• Others

Product

• Tablets
• Injections
• Urethral Suppository
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Impotence Agents Market Regional Analysis/Insights

The global impotence agents market is analysed and market size insights and trends are provided by product, indication, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global impotence agents market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global impotence agents market throughout the forecasted period due to increasing hypertension and diabetes patients and increased prevalence of erectile dysfunction in males.

North America dominates the market due to increasing initiatives taken by the pharmaceutical organizations to generate novel formulations.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Impotence Agents Market Share Analysis

El panorama competitivo del mercado global de agentes para la impotencia proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado global de agentes para la impotencia.

Los actores clave que operan en el mercado global de agentes para la impotencia incluyen:

• Pfizer Inc (Estados Unidos)
• Mylan NV (Estados Unidos)
• Novartis AG (Suiza)
• Hikma Pharmaceuticals plc (Reino Unido)
• Aurobindo Pharma (India)
• Abbvie Inc (Estados Unidos)
• Melinta Therapeutics, LLC (Estados Unidos)
• Janssen Global Services, LLC (Estados Unidos)
• Compañía Bristol-Myers Squibb (Estados Unidos)
• GSK plc. (Reino Unido)
• Bayer AG (Alemania)
• Industrias farmacéuticas Teva Ltd. (Israel)
• Lilly (Estados Unidos)
• AstraZeneca (India)

SKU-54079